These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14533077)

  • 1. [Levetiracetam in children and adolescents with epilepsy].
    Herranz JL
    Rev Neurol; 2003 Sep 16-30; 37(6):558-60. PubMed ID: 14533077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness and tolerability of levetiracetam in 43 children and adolescents with epilepsy].
    Herranz JL; Rufo-Campos M; Arteaga R
    Rev Neurol; 2003 Dec 1-15; 37(11):1005-8. PubMed ID: 14669138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness and safety of levetiracetam in 133 children with medication resistant epileptic seizures].
    Herranz JL; Prats-Viñas JM; Campistol J; Campos-Castelló J; Rufo-Campos M; Casas-Fernández C; Arteaga R; García-Ribes A; Conill JJ; Domingo-Jiménez R
    Rev Neurol; 2006 Oct 1-15; 43(7):393-7. PubMed ID: 17006857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood.
    von Stülpnagel C; Kluger G; Leiz S; Holthausen H
    Epilepsy Behav; 2010 Feb; 17(2):193-8. PubMed ID: 20045383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P; McCarthy M; Doherty CP; Delanty N
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam in refractory epilepsy: a prospective observational study.
    Mohanraj R; Parker PG; Stephen LJ; Brodie MJ
    Seizure; 2005 Jan; 14(1):23-7. PubMed ID: 15642496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of levetiracetam in refractory childhood epilepsy syndromes.
    Lagae L; Buyse G; Deconinck A; Ceulemans B
    Eur J Paediatr Neurol; 2003; 7(3):123-8. PubMed ID: 12788038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New onset paediatric epilepsy in 1-5 years age group children--approach to management in a tertiary care centre with newer anti-epileptic levetiracetam.
    Barik KL; Paul UK; Bhattacharyya AK; Adhikary A; Agarwal G; Rana KS
    J Indian Med Assoc; 2014 Feb; 112(2):100-2. PubMed ID: 25935964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS; Benatar M
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid onset of action of levetiracetam in refractory epilepsy patients.
    French J; Arrigo C
    Epilepsia; 2005 Feb; 46(2):324-6. PubMed ID: 15679515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study.
    Alsaadi TM; Shatzel A; Marquez AV; Jorgensen J; Farias S
    Seizure; 2005 Mar; 14(2):139-42. PubMed ID: 15694569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
    Tanaka S; Tanaka T
    Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.
    Cramer JA; Arrigo C; Van Hammée G; Gauer LJ; Cereghino JJ
    Epilepsia; 2000 Jul; 41(7):868-74. PubMed ID: 10897159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
    Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S
    Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
    Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
    Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
    Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.